Clinical Trial Update: Dantrolene for Treatment of Hyperthermia in Subarachnoidal Hemorrhage (SAH) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating dantrolene for treatment of hyperthermia in subarachnoid hemorrhage, which was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperthermia
• Subarachnoid Hemorrhage

Drugs mentioned

• Dantrolene (dantrolene)

Snippet

Sponsor: Medical University of Vienna | Conditions: Hyperthermia | Phase 2, Phase 3 | Status: TERMINATED